Business Standard

Sun Pharma regains Rs 1 trillion m-cap after surging 38% in four days

The stock was trading close to its 52-week high of Rs 480, touched on April 10, 2019

drug, medicine, pharmaceutical, pharma
Premium

Most analysts believe Indian pharma sector’s has been relatively resilient to the Covid-19 disruption

SI Reporter Mumbai
Shares of Sun Pharmaceuticals Industries were trading higher for the fourth straight day, up 8.5 per cent to Rs 474 on the BSE on Thursday on expectation of improvement in the company's outlook.

The drug firm's stock was trading close to its 52-week high of Rs 480, touched on April 10, 2019. In the past four days, it has rallied 38 per cent, as compared to 10 per cent rise in the S&P BSE Sensex and 23 per cent up move in S&P BSE Healthcare index.

Sun Pharma has regained the market-capitalisation of Rs 1-trillion after a sharp

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in